News

ORIC Pharmaceuticals Announces Key Participation in Investor Events

ORIC Pharmaceuticals Announces Key Participation in Investor Events

Upcoming Investor Conference Participation by ORIC Pharmaceuticals

In an exciting development for investors and stakeholders, ORIC Pharmaceuticals, Inc. (NASDAQ: ORIC), a forward-thinking clinical stage oncology company, is set to participate in several significant investor events this coming November. These conferences offer a valuable platform for the company to engage with the investment community, share insights, and discuss its innovative approaches to overcoming therapeutic resistance in cancer treatment.

Guggenheim's 2nd Annual Healthcare Innovation Conference

Taking place on a prominent stage, the management team from ORIC Pharmaceuticals will participate in a fireside chat at Guggenheim's 2nd Annual Healthcare Innovation Conference. On November 11, buy-side and sell-side analysts along with healthcare professionals can expect to gain insights at 1:30 p.m. ET. This engaging forum is an excellent opportunity for both industry veterans and new entrants to uncover the latest trends in oncology.

Stifel 2025 Healthcare Conference

On November 12, ORIC will also partake in one-on-one meetings at the Stifel 2025 Healthcare Conference. These personalized discussions will allow the management team to connect directly with potential investors, discuss company strategies, and delve deeper into the unique challenges the company is addressing with their groundbreaking drug candidates.

Jefferies London Healthcare Conference

Lastly, ORIC Pharmaceuticals will be represented at the Jefferies London Healthcare Conference on November 19, participating in a fireside chat at 2:30 p.m. GMT. This international presence not only highlights ORIC's commitment to transparency but also its ambition to showcase their critical work across borders and to a global audience, emphasizing the impact of their clinical trials and innovations.

Webcasts and Replay Availability

For those unable to attend these conferences in person, ORIC will provide webcasts of the fireside chat discussions. These can be accessed through the investor relations section of ORIC's official website. It’s noteworthy that replays will remain available for 90 days after each event, ensuring that investors and interested parties can catch up on essential insights and information shared during these important discussions.

About ORIC Pharmaceuticals, Inc.

ORIC Pharmaceuticals is dedicated to enhancing patient outcomes by focusing on mechanisms of resistance to cancer therapies. Their lead product candidates include ORIC-944, an allosteric inhibitor targeting the polycomb repressive complex 2 (PRC2), aimed at treating prostate cancer, and enozertinib (ORIC-114), which is a brain-penetrant inhibitor targeting specific EGFR and HER2 mutations across various genetically defined cancers. With headquarters in both South San Francisco and San Diego, ORIC strives to lead innovations in oncology.

Contact Information

For further inquiries, interested parties can contact Dominic Piscitelli, the Chief Financial Officer of ORIC Pharmaceuticals, via email at dominic.piscitelli@oricpharma.com. Alternatively, general inquiries can be directed to info@oricpharma.com.

Frequently Asked Questions

What is ORIC Pharmaceuticals focused on?

ORIC Pharmaceuticals is focused on developing innovative treatments that address the mechanisms of therapeutic resistance in cancer.

When is ORIC participating in the upcoming investor conferences?

ORIC Pharmaceuticals will participate in various investor conferences throughout November, including events hosted by Guggenheim, Stifel, and Jefferies.

How can investors access the webcasts of the conferences?

Investors can access webcasts of the fireside chats through the investor relations section on ORIC's official website, with replays available for 90 days.

What are ORIC's lead product candidates?

ORIC's main product candidates are ORIC-944, targeting prostate cancer, and enozertinib (ORIC-114), aimed at multiple genetically defined cancers.

Who can I contact for more information regarding ORIC Pharmaceuticals?

Dominic Piscitelli, the Chief Financial Officer, is the main contact person, and inquiries can be sent to his email or the general info email at ORIC.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

HK Boosts Oversight of Building Repairs Post-Blaze

Updated Category News Views 144

Big Moves After a Tragic Fire Hong Kong's revamping its approach to building maintenance and oversight, clearly in reaction to the horrific Wang Fuk Court blaze last year. That fire didn't just leave scars; it blew open glaring gaps in the city's oversight of building repairs. The government's now jumping into action by launching a raft of measures aimed at preventing...

Continue Reading
HanAll F&B Pioneers New Path for Domestic Rice Noodles

Updated Category News Views 173

New Spin on an Old Favorite: Rice Noodles Forget about the same old wheat noodles clogging up the pantry. HanAll F&B is revamping the noodle game with a homegrown twist, setting sights on a future where Korean rice isn't just for steaming, soup, or sushi. This outfit from Taebaek, Gangwon, has got its hands deep in the rice flour, finessing a patent that aims to make...

Continue Reading
Fluence Energy Faces Class Action: Investors Beware

Updated Category News Views 116

Storm Clouds Over Fluence Energy I'll tell you, I ain't surprised when companies face the music for dressing up their books. Fluence Energy, Inc. (NASDAQ: FLNC)—those wallopers are now caught in a legal maelstrom with a securities fraud class action lawsuit hanging over their heads. It's hard to feel sorry for 'em when the writing's on the wall. Allegations and...

Continue Reading
Lawsuit Hits San Ramon Medical: Wages, Breaks in Dispute

Updated Category News Views 98

Legal Storm Unleashes on San Ramon Regional In the world of legal entanglements, San Ramon Regional Medical Center found itself on the receiving end of the latest workforce fuss. Allegations flying from a class action lawsuit claim the center's brass didn't hold up their end of the California Labor Code, particularly in providing legit meal breaks and rest periods. Now,...

Continue Reading
Duolingo Investors Must Weigh Legal Options Now

Updated Category News Views 141

Pressure Mounts on Duolingo Amid Legal Turmoil Well, here's a riddle solved with a lawsuit: when an app's growth hits the brakes, the lawyers seem to get moving fast. It seems like Duolingo, Inc. (NasdaqGS: DUOL) is learning a harsh lesson—not exactly in Spanish or French, but in the courtroom. They've been slapped with a securities class action, and it ain't looking...

Continue Reading
Purina's Docuseries Wins Big at Daytime Emmys

Updated Category News Views 154

Unleashing a Winning Streak Forget stock price fluctuations—Purina Films has struck gold. In a world where brand stories often fall flat or feel contrived, Purina's 'A Different Breed' docuseries just bagged three Daytime Emmy® Awards. It's not every day you see corporate storytelling make a splash like this, but when you blend pets and riveting narratives, magic...

Continue Reading
BAIC FOTON Eyes Africa for Bold Expansion Moves

Updated Category News Views 157

Pushing the Pedal to the Metal in Africa So here's the thing. When a company like BAIC FOTON sets its sights on Africa, you best believe they're not just twiddling their thumbs. Coming off a strong streak in the commercial vehicle game—topping China's sales for 21 years and exports for 15—their ambitions are now married to a keen interest in Africa's burgeoning...

Continue Reading
Main Street Merger Faces Scrutiny: What It Means for Shareholders

Updated Category News Views 51

Under the Radar, but Not for Long Ah, mergers—those grand gestures in corporate America that promise growth, synergy, and shareholder value. But not every deal is a head-turner; some fly under the radar until someone grabs the magnifying glass. And that's exactly what's happening with Main Street Financial Services Corp.'s (OTC: MSWV) proposed merger with First...

Continue Reading
CMRE Facing Legal Heat Over Wage Allegations

Updated Category News Views 96

Another Day, Another Lawsuit Ah, work. It’s what gets us up in the morning, whether we like it or not. Yet, for many, it can feel more like a dubious hustle when the rewards don't match the effort. Now, CMRE Financial Services, Inc. finds itself under the legal microscope, thanks to a fresh class-action lawsuit filed by the legal eagles at Blumenthal Nordrehaug Bhowmik...

Continue Reading
MongoDB Faces Continued Legal Scrutiny Amid Growth Issues

Updated Category News Views 115

MongoDB's Legal Marmite: Sticky and Spreading Well, here we are, rolling up our sleeves with MongoDB, Inc. (NasdaqGM: MDB) in the spotlight again, not for some glorious tech breakthrough but a legal brouhaha. The whip of the market is as familiar as an old leather boot to traders like us. This time, we've got Kahn Swick & Foti, LLC (KSF), spearheaded by former Attorney...

Continue Reading

Top 5 Most Recently Viewed Articles

Savara Inc. Class Action Update: Key Dates and Participation Info

Updated Category News Views 223

Overview of the Savara Inc. Class Action Lawsuit Savara Inc. is a biopharmaceutical company that specializes in developing treatments for rare respiratory diseases. The company's significant product candidate, MOLBREEVI, has been the center of attention due to its regulatory submission process with the FDA. A class action lawsuit has recently been initiated on behalf of...

Continue Reading
Join the Class Action Against Evolv Technologies Holdings Today

Updated Category News Views 78

Take Action Against Evolv Technologies Holdings, Inc. Attention shareholders of Evolv Technologies Holdings, Inc. (NASDAQ: EVLV)! If you purchased shares during a recent class period, you may want to pay close attention to this important announcement. The Gross Law Firm is actively encouraging shareholders to contact them for potential lead plaintiff appointment. This is...

Continue Reading
Market Update: Dow Drops Over 250 Points, Boeing Reports Loss

Updated Category News Views 124

Market Overview U.S. stocks opened lower recently, witnessing a significant dip as the Dow Jones index fell by more than 250 points. This downward trend set the tone for trading on that Wednesday. Market Performance After the market opened, the Dow was down by 0.63%, trading at 42,654.26. The NASDAQ also experienced a decline of 0.47%, resting at 18,486.46. Additionally,...

Continue Reading
ALTRA | SANEXEN Celebrates Environmental Excellence Award

Updated Category News Views 147

ALTRA | SANEXEN Achieves Milestone in Environmental Restoration ALTRA | SANEXEN has recently received a prestigious accolade for their groundbreaking work in the field of environmental remediation. The company, in collaboration with Qikiqtaaluk Environmental, was honored with the esteemed Brownie Award for their innovative approaches to decontaminating critical sites...

Continue Reading
Teamsters Rally for Union Recognition Among Amazon Drivers

Updated Category News Views 114

Amazon Drivers Demand Union Recognition In a powerful show of unity, hundreds of Teamsters drivers at the Amazon DFX4 facility have rallied together with a clear message for the e-commerce giant: they want their union recognized. Workers are coming together to negotiate a contract that will address the pressing issues of low pay and unsafe working conditions. The movement...

Continue Reading